跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HYDRALAZINE HYDROCHLORIDE INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
HYDRALAZINE HYDROCHLORIDE INJECTION, USP
Authorized
STANDARD
HYDRALAZINE HYDROCHLORIDE INJECTION, USP
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5eaba2953f6c052f
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
5eaba2953f6c052f
Drug Approval Canada Name
HYDRALAZINE HYDROCHLORIDE INJECTION, USP
Product Name
HYDRALAZINE HYDROCHLORIDE INJECTION, USP
Status
Marketed
Status Date
2023-07-26
Original Market Date
2023-07-26
Din
02516160
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
24:08.20
Atc Original
C02DB02 HYDRALAZINE
Atc Name
c 02 db 02
Aig Number
0107444005
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
HYDRALAZINE HYDROCHLORIDE
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5eaba2953f6c052f
Type
Standard
Back to Health Canada Approvals